Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Wegovy: Opportunities and Risks of Semaglutide

Summary by ndr.de
The new Wegovy Abnehmpille with the active ingredient semaglutide is now available for the treatment of obesity. How effective is the tablet? What are the side effects? Who pays the cost?
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

Thüringer AllgemeineThüringer Allgemeine

Losing Weight: Wegovy & Co. Stop? Experts Observe Violent Jojo Effect

Losing weight with Wegovy or Mounjaro was successful. Why not just stop the expensive medication? Just not, warns a researcher.

·Erfurt, Germany
Read Full Article
ndr.dendr.de

Wegovy: Opportunities and Risks of Semaglutide

The new Wegovy Abnehmpille with the active ingredient semaglutide is now available for the treatment of obesity. How effective is the tablet? What are the side effects? Who pays the cost?

·Hamburg, Germany
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ndr.de broke the news in Hamburg, Germany on Wednesday, July 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Obesity icon

Obesity

Germany icon

Germany

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal